Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Sci. STKE, 21 May 2002
Vol. 2002, Issue 133, p. pe27
[DOI: 10.1126/scisignal.1332002pe27]

PERSPECTIVES

TRAF1: Lord Without A RING

Juan M. Zapata* and John C. Reed*

The Burnham Institute, 10901 N. Torrey Pines Rd, La Jolla, CA 92037, USA.

Abstract: Tumor necrosis factor (TNF) receptor-associated factors (TRAFs) constitute a family of adaptor proteins that associate with the cytosolic tail of particular TNF-family receptors (TNFR) and regulate cytokine signaling by linking TNFRs with downstream protein kinases, ubiquitin ligases, and other effector proteins. A total of six members of this family (TRAF1-6) have been identified in mammals. TRAF1 is unique among TRAFs because it lacks a RING finger domain present in TRAF2-6 that has been shown to be required for TRAF2- and TRAF6-mediated activities. TRAF1 also has the most restricted expression among TRAFs, and is found almost exclusively in activated lymphocytes, dendritic cells, and certain epithelia. Recent evidence obtained from TRAF1-/- mice shows that TRAF1-deficient T cells are hyper-responsive to TNF-α, having increased T cell receptor (TCR)-dependent T cell proliferation rates in vitro. Also, these TRAF1-/- mice had increased sensitivity to TNF-α-induced skin necrosis in vivo. These results support a role for TRAF1 as a negative regulator of signaling by certain TNF-family receptors. This review summarizes current knowledge about TRAF1, focusing on the new information provided by these TRAF1-deficient mice. Also, the pros and cons of TRAFs as potential targets for drug discovery are discussed.

*Corresponding authors. E-mail: jzapata{at}burnham.org jreed{at}burnham.org

Citation: J. M. Zapata, J. C. Reed, TRAF1: Lord Without A RING. Sci. STKE 2002, pe27 (2002).

Read the Full Text

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
CD40 Ligation Protects Bronchial Epithelium against Oxidant-Induced Caspase-Independent Cell Death.
A. M. Merendino, F. Bucchieri, R. Gagliardo, A. Daryadel, F. Pompeo, G. Chiappara, R. Santagata, V. Bellia, S. David, F. Farina, et al. (2006)
35, 155-164
   Abstract »    Full Text »    PDF »
CD40: A Growing Cytoplasmic Tale.
M. M. Harnett (2004)
Sci. STKE 2004, pe25
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882